Location History:
- Dejeon, KR (2009)
- Daejeon, KR (2019 - 2021)
Company Filing History:
Years Active: 2009-2025
Title: Innovator Spotlight: Sungwhan An Revolutionizing Early Detection of Colorectal Cancer Precursors
Introduction: Sungwhan An, a brilliant inventor based in Daejeon, South Korea, has made significant contributions to the field of molecular diagnostics with his groundbreaking innovations. With a keen focus on early detection of precancerous lesions, An's work is at the forefront of advancing medical technologies.
Latest Patents:
1. Method for multiplex detection of methylated DNA: An's latest patent showcases a method for detecting methylation of target DNA in a multiplex manner. By utilizing a unique approach involving oligonucleotides and universal primers, this innovation paves the way for more efficient and accurate detection of DNA methylation.
2. Method for detecting precancerous lesions: Another one of An's recent patents highlights the novel use of the syndecan-2 (SDC2) gene as a CpG methylation biomarker for detecting precancerous lesions, particularly in colorectal cancer. This method enables early diagnosis of colorectal precancerous lesions, offering a crucial advantage in the timely treatment of this condition.
Career Highlights: Sungwhan An is a key figure at Genomictree, Inc., a leading biotechnology company known for its cutting-edge research in genomics and molecular diagnostics. With a portfolio of three patents to his name, An's expertise in developing innovative diagnostic tools has earned him recognition in the scientific community.
Collaborations: An has collaborated closely with notable peers in the field, including TaeJeong Oh and Tae Jeong Oh. Together, they have synergized their efforts to enhance the accuracy and efficiency of molecular diagnostic methods, ensuring that their innovations have a meaningful impact on healthcare practices.
Conclusion: Sungwhan An's inventive spirit and dedication to advancing molecular diagnostics have positioned him as a trailblazer in the field of early cancer detection. His patents not only demonstrate his technical prowess but also underscore his commitment to improving patient outcomes through innovative medical technologies. An's contributions are invaluable in the fight against colorectal cancer, offering hope for early detection and effective treatment strategies.